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The clinical picture of liver disease in endemic areas ofSchistosomiasis mansoni differs in
many ways from that observed in alcoholic and other types of cirrhosis. In hepatosplenic
schistosomiasis there is predominance of the clinical manifestations of portal hypertension,
e.g., bleeding esophageal varices, while ascites, jaundice, and hepatic precoma or coma are
much less common. Ammonia tolerance is usually normal and helps explain the low mortality
rate during bleeding. Of special interest is the observation of a high incidence of persistent
hepatitis B surface antigenemia among patients with hepatosplenic schistosomiasis, suggest-
ing increased susceptibility of such patients to the development of virus-induced chronic
active hepatitis.
INTRODUCTION
Schistosomiasis is a disease caused by trematodes. These organisms alternate
generations between fresh water snails that are the intermediate hosts in which they
multiply and mammals that are the definitive hosts in which they cause the disease.
Patients with low worm burdens have silent schistosomiasis. Such patients exhibit
no evidence ofdisease, and the existence oftheinfestation can bedetermined only by
the presence ofthe ova in the stools. Although ova can sometimes be demonstrated
in the liver, there are no signs or symptoms of hepatic involvement. Hepatosplenic
schistosomiasis (HSS) exists when the hepatic worm burden is great enough to
cause clinical liver disease. In the compensated state HSS is characterized by
hepatomagaly, typically of the left lobe, splenomegaly and portal hypertension.
Liver function is usually normal. Decompensated HSS is the late stage of the
disease when advanced fibrosis complicated by malnutrition, increasing age, or
other factors induces ascites, portalsystemic encephalopathy, and liver failure.
Schistosomal liver disease is a benign process. Between 6 and 10% of all infected
persons in an endemic region have the hepatosplenic form of schistosomiasis, and
most ofthem lead an entirely normal life. Since there are approximately 200 million
infected persons in the world (1), the number ofpatients with thehepatosplenic form
of the disease is overwhelming. The common idea that liver involvement by
schistosomiasis is a bad disease derives from the description ofpatients hospitalized
in major medical centers, a highly selected sample of the most severe cases. Ob-
servation of these advanced cases led many clinical investigators to the conclusion
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that hepatosplenic schistosomiasis was clinically similar to hepatic cirrhosis ofother
etiologies, thus coining the erroneous term schistosomotic cirrhosis.
Despite some superficial similarities, there are marked clinical differences be-
tween hepatosplenic schistosomiasis and cirrhosis.
Aside from the pathological picture, which is unmistakably different, these
diseases differenormously in the clinical features that characterize them.
CLINICAL FEATURES
1. ClinicalAppearance
The major clinical difference between hepatosplenic schistosomiasis (HSS) and
cirrhosis is the predominance of the clinical manifestations of portal hypertension
overimpairment ofhepatic function.
The stigmata of chronic liver disease are generally absent, and the liver function
tests are usually within normal limits. Occasionally an elevation of the y-globulins
FIG. 1. Compensated hepatosplenic schistosomiasis. The grossly enlarged spleen is shown by the
crosshatched markings. The left lobe of the liver is indicated. The right lobe of the liver is not palpable.
Otherwise the patient looks healthy.
370REVIEW: HEPATOSPLENIC SCHISTOSOMIASIS
and moderate elevation of the alkaline phosphatase exist. Such individuals are said
to have compensated hepatosplenic schistosomiasis (2). The large spleen and the
prominent, hard left lobe ofthe liver are the only clinical clues that thediseaseexists
(Fig. 1). These cases are much more like extrahepatic portal vein thrombosis than
like cirrhosis.
A small minority of cases, with the same degree ofportal hypertension, will pre-
sent with ascites and a few or all ofthe clinical stigmata ofchronic liverdisease (Fig.
2). The laboratory tests in these patients often show hypoalbuminemia and variable
degrees ofderangement ofall other tests ofliver function. These are the cases ofde-
compensated hepatosplenic schistosomiasis. It is sometimes clinically impossible to
ascertain the nature ofthe liver disease without the help ofa liver biopsy. All grada-
tions ofintermediate forms between the well-compensated and the severely decom-
pensated cases occur.
The reason why some cases decompensate is not known. Repeated hemorrhages
from varices may lead to ischemic necrosis of the liver (3, 4), but it is common to
1
FIG. 2. Decompensated hepatosplenic schistosomiasis. The left lobe of the liver and the spleen are
enlarged as outlined. In addition, the patient shows gross ascites,gynecomastia, and emaciation.
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TABLE 1
Esophageal Varices in Hepatosplenic Schistosomiasis
Esophagoscopy Barium swallow
Number examined Varices present Number examined Varices present
All patients 153 143 (93%) 94 73 (78%)
History ofbleeding 103 102 (99%) 68 60 (88%)
No history ofbleeding 50 41 (82%) 26 13 (50%)
find well-compensated cases with a history ofmany episodes ofvariceal bleeding and
decompensated patients who have never bled. In a blind histologic evaluation of
autopsy material, Cheever and Andrade (5) reported active inflammation of the
portal triads with destruction ofthe limiting plate and piecemeal necrosis in patients
with decompensated hepatosplenic schistosomiasis. This pattern, which is typical of
chronic active hepatitis, was not seen in compensated HSS.
2. Esophageal Varices
Esophageal varices occur twice as frequently in HSS as they do in Laennec's cir-
rhosis (6, 7). Indeed, of 153 patients with hepatosplenic schistosomiasis in our own
experience, esophageal varices were demonstrated by direct visualization with an
Eder-Hufford esophagoscope in 93% compared to less than 50% in patients with al-
coholic cirrhosis (8, 9). This high incidence might have been influenced by selection,
since many of these patients sought hospital attention because ofupper gastrointes-
tinal hemorrhage. When we examined 50 patients in the same series who did not
have a history of bleeding, the incidence of varices by esophagoscopy was 82%
(Table 1). The pattern was similar for varices diagnosed by barium swallow, but the
incidence ofvarices was lowerin all categories, probably reflecting thediagnostic su-
periority ofendoscopy.
3. Tolerance to Gastrointestinal Hemorrhage
Because of their extensive deep portal collateral circulation and high incidence of
esophageal varices, gastrointestinal hemorrhage is a common event among patients
with schistosomiasis and often is the only reason for which compensated cases seek
medical care. Tolerance to hemorrhage is well established, and the mortality rate
from bleeding varices is far below that observed in cirrhotic patients. In cirrhosis the
mortality varies from 30 to 80% (10-12); in a small, controlled series in
schistosomiasis it was only 8% (Table 2).
4. Variceal Bleeding:Response to Medical Treatment
Because of their good tolerance to hemorrhage, the medical management of rup-
tured esophageal varices in schistosomiasis seems to be very effective. Spontaneous
TABLE 2
Gastrointestinal Hemorrhage in Hepatosplenic Schistosomiasis
Total
Number Percent
Patients 35
Hemorrhages 49
Spontaneous cessation 14 29
Precoma or coma 4 8
Deaths 4 8
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TABLE 3
Controlled Study of Upper Gastrointestinal Hemorrhage in Hepatosplenic Schistosomiasis
Total Stopped hemorrhage Failure
Treatment Number Percent Number Percent Number Percent
Vasopressina 14 100 13 93 1 7
Sengstaken tube 14 100 12 86 2 14
aintravenous.
cessation of the hemorrhage before any treatment is started occurs in about one-
third of the cases. In our controlled trial, intravenous injection of vasopressin and
esophageal tamponade with the Sengstaken-Blakemore tube were equally suc-
cessful in controlling the hemorrhage (Table 3). Despite the absence of a significant
difference in efficacy between the two methods, we favor the use of vasopressin in
these patients because ofits simplicity and the absence ofserious complications.
5. Hepatic Coma andAmmonia Tolerance
The low mortality rate during hemorrhage reflects the rarity with which patients
with schistosomiasis develop hepatic coma (Table 2). The majority ofthese patients,
who belong in the compensated category, tolerate well the overload of ammonia in
blood brought about by the hemorrhage into the gut. Only patients with decom-
pensated HSS show a rise in their arterial blood ammonia (13). A similar pattern
has been observed after the administration ofammonium chloride (Fig. 3).
6. Abdominal Wall Collaterals
Despite their extensive deep portal collateral circulation as shown by esopha-
goscopy or splenoportography, superficial collaterals such as dilated veins on the
abdominal wall are uncommon. The classical "caput medusae" is practically never
seen. Venous collaterals on the abdominal wall are clearly not a sensitive clinical
index ofportal hypertension.
ORAL AMMONIA TOLERANCE TEST
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FIG. 3. Ammonia tolerance test in schistosomiasis. Increment above fasting levels of arterial am-
monia concentration 45 min after 5 g of ammonium citrate is small in patients with compensated he-
patosplenic schistosomiasis and large in patients with decompensated disease. Increments are not further
increased when cirrhosis develops.
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7. Ascites
The presence of ascites is the major clinical sign ofdecompensation. It is absent in
all compensated cases and is independent of the severity of the portal hypertension.
Occasionally, severe hemorrhage induces the development of transient ascites and
represents temporary decompensation of a borderline case. In such cases there is
usually a prompt response to salt restriction and to diuretics, and the patients may
go back to a normal diet after the bleeding episode.
8. Jaundice
Mild to moderate hyperbilirubinemia in schistosomiasis occurs in only a few of
the decompensated cases, and its presence always raises the suspicion of chronic
active hepatitis. In patients with schistosomal cor pulmonale and passive congestion
ofthe liver, deepjaundice may ensue. After portacaval shuntsjaundice may also ap-
pear due to hepatic failure, hemolysis, and other factors (14).
9. Diabetes
Unlike Laennec's cirrhosis (15), the incidence ofdiabetes does not seem to be in-
creased among patients with hepatosplenic schistosomiasis, at least in the com-
pensated form. This subject is now under investigation in our and other laboratories
(16).
10. Dwarfism
Adolescents with hepatosplenic schistosomiasis may present with variable
degrees of dwarfism and sexual immaturity (17). Protein undernutrition may be
responsible for the lack of normal growth. Although the production ofhypophyseal
hormones has been shown to be normal in such patients (18), the hypothesis of a pe-
ripheral blockade to the action ofgrowth hormone and gonadotrophins has not been
excluded.
11. ProlongedSalmonellaSepticemia
While patients with Laennec's cirrhosis may have gram-negative peritonitis,
patients with hepatosplenic schistosomiasis may develop prolonged septicemia
caused by Salmonella (19, 20) and, perhaps, other gram-negative bacteria. The du-
ration ofthe bacteremia seems to be associated with the schistosome parasiteperse
rather than an immunological defect ofthe host, since it has been demonstrated that
the bacteria adhere to the cuticula ofthe worm and can be entirely eliminated by the
treatment of the parasite (19, 21, 22). Unlike cirrhosis, bacterial peritonitis is not a
common event, probably due to the relative rarity ofascites, thesine qua non ofcir-
rhotic peritonitis.
12. Response to Surgical Treatment ofPortal Hypertension
For the elective surgical treatment of the portal hypertension in schistosomiasis,
the major procedures such as portacaval anastomosis have practically been
abandoned by most Brazilian surgeons. This type of operation, although very
efficient in preventing variceal hemorrhage, may result in progressive hepatic dis-
function (18), leading to death in liver failure in a high proportion ofpatients, and is
probably worse than the basic disease. Curiously, the splenectomy, which does not
seem to decrease the chance of further hemorrhagic episodes significantly, presents
a much better survival rate. The splenorenal shunt, which still has the preference of
some surgeons, occupies an intermediary position, probably because it is not so
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efficient as the direct portacaval shunt in decreasing the hepatic blood flow. Most
specialists will give preference to a combination of splenectomy plus either trans-
esophageal ligation of the varices or another type of azygoportal disconnection. It
should be emphasized, however, that there is no well-controlled prospective study to
justify these surgical preferences.
13. Association ofHepatosplenicSchistosomiasis with Hepatitis BAntigenemia
In a study in progress in our laboratory, Lyra (25) has found a high incidence of
persistent hepatitis B surface antigenemia (HBSAg) among cases with hepatosplenic
schistosomiasis. Decompensated cases showed a higher proportion of positive
HB,Ag (12%) than compensated cases (7.7%). Both, however, had antigenemia in a
much higher incidence than a large control group (1.4%), which included patients
with intestinal schistosomiasis. It is of interest to note that the antigenemia has
proven to be persistent in all cases for at least several months and that active inflam-
mation on the liver biopsy was also more prevalent among the cases positive for the
Au antigen (26). It seems possible that patients with hepatosplenic schistosomiasis
may be especially susceptible to the development of hepatitis B virus-induced
chronic active hepatitis, thus explaining the progression of some cases to a full
blown picture ofcirrhosis.
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